Published Jun 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

Member News
The MoU was signed during the official, 40thanniversary celebration ceremony of the Shanghai-Rotterdam Sister City Relationship.

Related or similar articles

November 14, 2018

Science incubator Labshares Newton is Set to Expand

The next groundbreaking medical discovery could be made right here in the city, as companies conduct research and experiments at Labshares Newton, an “incubator lab” on Bridge Street that is in the process of expanding.
Labshares News
June 28, 2024

Incubators vs. Shared Laboratories: Finding the Best Fit for Your Biotech Startup

Labshares News
March 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

First in vivo validation of KLRG1 as a new cancer immunotherapy target
Member News